Standard Modifiable Cardiovascular Risk Factors and Prognosis of Acute Coronary Syndrome in Younger Patients

被引:4
|
作者
Chen, Xu [1 ]
Liu, Han-xiong [1 ]
Yu, Xiu-qiong [1 ]
Yang, Si-qi [1 ]
Qi, Ling-yao [1 ]
Cai, Lin [1 ]
机构
[1] Southwest Jiaotong Univ, Peoples Hosp Chengdu 3, Dept Cardiol, Affiliated Hosp, Chengdu, Sichuan, Peoples R China
来源
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2021年 / 31卷 / 12期
关键词
Coronary artery disease; Acute coronary syndrome; Middle aged; Risk factors; Prognosis; HEART-DISEASE; SMOKING-CESSATION; INFARCTION; ADULTS; TRENDS; SEX; AGE;
D O I
10.29271/jcpsp.2021.12.1394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate standard modifiable cardiovascular risk factors (SMuRFs) and prognosis of patients with acute coronary syndrome (ACS) aged 50 years or younger. Study Design: An observational study. Place and Duration of Study: Eleven general hospitals in Chengdu, Sichuan Province, China, from January 2017 to June 2019. Methodology: Patients with ACS were stratified into younger group (<_50 years) and older group (>50 years). The baseline characteristics and prognosis were compared for two groups. Survival analysis was used to assess the long-term prognosis. Results: Among a total of 1982 ACS patients, 322 (16.2%) were of <_50 years. Compared with older patients, younger patients were more likely to have at least one SMuRFs (90.0%vs. 84.3%, p=0.013). The younger group had a higher prevalence of smoking (62.8% vs. 34.1%, p <0.001) and hypercholesterolemia (36.2% vs. 23.4%, p <0.001) compared with the older group. Younger male patients were more likely to have at least one SMuRFs than younger female patients (91.6%vs. 74.1%, p = 0.011). After the follow-up of 15 (10, 22) months, the cumulative rates of major adverse cardiovascular and cerebrovascular events (MACCE) of the younger patients were significantly lower than those in the older patients [hazard ratio (HR): 0.2661, 95% confidence interval (CI): 0.1932 0.3665, p <0.001]. Conclusion: Younger patients with ACS were more likely to have at least one SMuRFs; and were likely to have a better prognosis than older patients.
引用
收藏
页码:1394 / 1398
页数:5
相关论文
共 50 条
  • [1] Prognostic value of serum glycated albumin in acute coronary syndrome patients without standard modifiable cardiovascular risk factors
    Zhang, Xiaoming
    Du, Yu
    Guo, Qianyun
    Ma, Xiaoteng
    Shi, Dongmei
    Zhou, Yujie
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01)
  • [2] Prognostic significance of triglyceride-glucose index in acute coronary syndrome patients without standard modifiable cardiovascular risk factors
    Zhang, Xiaoming
    Du, Yu
    Zhang, Tianhao
    Zhao, Zehao
    Guo, Qianyun
    Ma, Xiaoteng
    Shi, Dongmei
    Zhou, Yujie
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [3] Standard modifiable cardiovascular risk factors in patients with acute coronary syndrome: A report from multicenter percutaneous coronary intervention registry
    Iwata, Juri
    Inohara, Taku
    Shiraishi, Yasuyuki
    Nakamaru, Ryo
    Niimi, Nozomi
    Ueda, Ikuko
    Suzuki, Masahiro
    Noma, Shigetaka
    Numasawa, Yohei
    Fukuda, Keiichi
    Kohsaka, Shun
    JOURNAL OF CARDIOLOGY, 2023, 81 (06) : 571 - 576
  • [4] Angiographic severity in acute coronary syndrome patients with and without standard modifiable risk factors
    Papazoglou, Andreas S.
    Farmakis, Ioannis T.
    Zafeiropoulos, Stefanos
    Moysidis, Dimitrios V.
    Karagiannidis, Efstratios
    Stalikas, Nikolaos
    Kartas, Anastasios
    Stamos, Konstantinos
    Sofidis, Georgios
    Doundoulakis, Ioannis
    Giannopoulos, Georgios
    Giannakoulas, George
    Sianos, Georgios
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [5] No standard modifiable cardiovascular risk factors in acute myocardial infarction: prevalence, pathophysiology, and prognosis
    Saito, Yuichi
    Tsujita, Kenichi
    Kobayashi, Yoshio
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2024, 39 (04) : 403 - 411
  • [6] Twenty-year trends in the prevalence of modifiable cardiovascular risk factors in young acute coronary syndrome patients hospitalized in Switzerland
    Mahendiran, Thabo
    Hoepli, Andre
    Foster-Witassek, Fabienne
    Rickli, Hans
    Roffi, Marco
    Eberli, Franz
    Pedrazzini, Giovanni
    Jeger, Raban
    Radovanovic, Dragana
    Fournier, Stephane
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 30 (14) : 1504 - 1512
  • [7] Sex differences in survival following acute coronary syndrome with and without standard modifiable risk factors
    Anand, Vickram Vijay
    Koh, Jaycie
    Teo, Tobias
    Chin, Yip Han
    Mahesh, Rishabh
    Chan, Mark Y.
    Figtree, Gemma A.
    Chew, Nicholas W. S.
    CLINICAL RESEARCH IN CARDIOLOGY, 2024, : 681 - 689
  • [8] Uric Acid Levels, Number of Standard Modifiable Cardiovascular Risk Factors, and Prognosis in Patients With Coronary Artery Disease: A Large Cohort Study in Asia
    Cui, Kongyong
    Song, Yanjun
    Yin, Dong
    Song, Weihua
    Wang, Hongjian
    Zhu, Chenggang
    Feng, Lei
    Fu, Rui
    Jia, Lei
    Lu, Ye
    Zhang, Dong
    Song, Chenxi
    Yang, Yuejin
    Dong, Qiuting
    Dou, Kefei
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (20):
  • [9] Progression of coronary atherosclerosis in patients without standard modifiable risk factors
    Mazhar, Jawad
    Figtree, Gemma
    Vernon, Stephen T.
    Galougahi, Keyvan Karimi
    Carlo, Julie
    Nissen, Steven E.
    Nicholls, Stephen J.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2020, 4
  • [10] Comparison of Mortality Outcomes in Acute Myocardial Infarction Patients With or Without Standard Modifiable Cardiovascular Risk Factors
    Sia, Ching-Hui
    Ko, Junsuk
    Zheng, Huili
    Ho, Andrew Fu-Wah
    Foo, David
    Foo, Ling-Li
    Lim, Patrick Zhan-Yun
    Liew, Boon Wah
    Chai, Ping
    Yeo, Tiong-Cheng
    Yip, James W. L.
    Chua, Terrance
    Chan, Mark Yan-Yee
    Tan, Jack Wei Chieh
    Figtree, Gemma
    Bulluck, Heerajnarain
    Hausenloy, Derek J.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9